Biodesix IDs Proteomic Signature for Predicting Response to GlobeImmune ... GenomeWeb The Biodesix researchers identified the signature via mass spec analysis of baseline plasma samples from 90 trial subjects. Using it they were able to predict late- versus early-recurrence in patients treated with GI-4000 as well as better and worse ... |
Friday, June 29, 2012
Biodesix IDs Proteomic Signature for Predicting Response to GlobeImmune ... - GenomeWeb
iwyqaxewun.wordpress.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment